At a glance
ClinicalIndex Comparison RecordN/ACompleted· 18 enrolled
Drug / intervention
CAVAdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Production of a Device to Obtain Continuous Ambulatory Vestibular Assessment (CAVA) - Healthy Volunteer Trial
In Brief
An observational study evaluating CAVA for Optokinetic Nystagmus. Completed, enrolled 18 participants across 1 site.
Detailed Summary
Clinical investigation of a medical device (CAVA) for recording eye movements. Healthy volunteers will wear the device for 23 hours a day, for 30 days. On 8 separate days of the trial they will induce optokinetic nystagmus (a normal reflex in response to full-field motion) by watching a short video of less than 1 minute in duration. The data will be analysed offline by a scientist, who will attempt to identify the dates that the nystagmus was induced.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsOptokinetic Nystagmus
CountriesUnited Kingdom
CollaboratorsUniversity of East Anglia, Medical Research Council
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartAug 2018
First PostedSep 2018
Primary CompletionDec 2018
Study CompletionApr 2019
TodayJul 2026
First PostedSep 7, 2018
Enrollment StartAug 23, 2018
Primary CompletionDec 12, 2018
Study CompletionApr 5, 2019
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 7.8 years ago
Interventions
CAVAdevice
prototype device for monitoring dizziness